Search results for "Methimazole"

showing 10 items of 12 documents

Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.

1999

A case of a very rare association of toxic adenoma and papillary carcinoma with Graves’ disease is presented. A 34-year-old woman developed Graves’ disease with mild ophthalmopathy. An ultrasound revealed diffuse thyroid enlargement with a hypoechoic pattern and a hypoechoic nodule with regular edges of 1.6 cm in diameter at the lower pole of the left lobe. A thyroid 131I scintiscan showed a diffuse and homogeneous 131I distribution. The 131I uptake (RAIU) was elevated. One year later, while still on a low dose of methimazole, the patient had a recurrence of hyperthyroidism following an iodine load from a contrast agent. A further thyroid ultrasound confirmed the previously described patter…

AdenomaAdultendocrine systemPathologymedicine.medical_specialtyendocrine system diseasesAdenomaEndocrinology Diabetes and MetabolismGraves' diseasemedicine.medical_treatmentThyroid carcinomaIodine RadioisotopesEndocrinologyAntithyroid AgentsCarcinomamedicineHumansNeoplastic transformationThyroid NeoplasmsUltrasonographyMethimazolebusiness.industryThyroidThyroidectomyNodule (medicine)medicine.diseaseCarcinoma PapillaryGraves DiseaseThyroxinemedicine.anatomical_structureThyroidectomyFemalemedicine.symptombusinessJournal of endocrinological investigation
researchProduct

Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease

2019

Abstract Context Scarce data exist regarding the relevance of stimulatory (TSAb) and blocking (TBAb) thyrotropin receptor antibodies in the management of Graves disease (GD). Objective To evaluate the clinical utility and predictive value of TSAb/TBAb. Design Prospective 2-year trial. Setting Academic tertiary referral center. Patients One hundred consecutive, untreated, hyperthyroid GD patients. Methods TSAb was reported as percentage of specimen-to-reference ratio (SRR) (cutoff SRR < 140%). Blocking activity was defined as percent inhibition of luciferase expression relative to induction with bovine thyrotropin (TSH, thyroid stimulating hormone) alone (cutoff > 40% inhibitio…

AdultMaleendocrine systemmedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and MetabolismGraves' diseaseClinical BiochemistryThyrotropinContext (language use)dilution analysisBiochemistryGastroenterologyThyrotropin receptorThyroid binding inhibitory immunoglobulinsYoung AdultMethimazoleEndocrinologyTSH-R stimulating antibodiesInternal medicineGraves hyperthyroidismmedicineHumansprospective trialProspective StudiesAutoantibodiesClinical Research Articlebiologybusiness.industryBiochemistry (medical)Receptors ThyrotropinMiddle AgedPrognosismedicine.diseaseeye diseasesGraves DiseaseTSH-R blocking antibodiesTiterEndocrinologyProspective trialbiology.proteinFemaleAntibodybusinessBiomarkersAcademicSubjects/MED00250Follow-Up Studiesmedicine.drugThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Nitric oxide mediates abnormal responsiveness of thyroid arteries in methimazole-treated patients.

2005

Objective: We studied the intervention of nitric oxide (NO), prostacyclin and endothelium-derived hyperpolarizing factor (EDHF) in mediating responses to acetylcholine in thyroid arteries from euthyroid and methimazole-treated (MT) patients. Design and methods: Branches of the superior thyroid artery were obtained from 19 euthyroid patients and 17 MT patients (euthyroid at the time of surgery) undergoing total thyroidectomy or hemithyroidectomy. Artery rings were suspended in organ baths for isometric recording of tension. Results and conclusions: Acetylcholine caused endothelium-dependent relaxation of greater magnitude in arteries from MT patients (pD2 (−log EC50) values were 7.68±0.19 in…

AdultMalemedicine.medical_specialtyPotassium ChannelsCharybdotoxinEndocrinology Diabetes and MetabolismMuscle RelaxationThyroid GlandApaminNitric OxideHyperthyroidismMuscle Smooth VascularSuperior thyroid arterychemistry.chemical_compoundBiological FactorsNorepinephrineEndocrinologyAntithyroid AgentsInternal medicinemedicine.arterymedicinePotassium Channel BlockersHumansEuthyroidEnzyme InhibitorsMethimazoleomega-N-Methylargininebusiness.industryThyroidGeneral MedicineArteriesMiddle AgedAcetylcholinemedicine.anatomical_structureEndocrinologychemistryApaminCirculatory systemPotassiumCalciumFemaleEndothelium VascularNitric Oxide SynthasebusinessAcetylcholinemedicine.drugBlood vesselArteryEuropean journal of endocrinology
researchProduct

High Titers of Thyrotropin Receptor Antibodies Are Associated With Orbitopathy in Patients With Graves Disease.

2018

AbstractContextSerum TSH receptor autoantibody (TSH-R-Ab) is a biomarker of Graves disease (GD). Studies have shown that the levels of this TSH-R-Ab have clinical significance.ObjectiveTo differentiate between thyroidal GD only and Graves orbitopathy (GD + GO).DesignControlled, follow-up study.SettingAcademic tertiary referral center for GD + GO.SubjectsSixty patients with GD, GD + GO, and controls.InterventionSerial serum dilution analyses with six automated, ELISA, and cell-based assays for TSH-R-Ab.Main Outcome MeasureDifferentiation among GD phenotypes.ResultsAll undiluted samples of hyperthyroid-untreated GD patients were positive with the six assays but became negative at dilution 1:9…

AdultMalemedicine.medical_specialtySerial dilutionEndocrinology Diabetes and MetabolismGraves' diseaseClinical Biochemistry030209 endocrinology & metabolismContext (language use)BiochemistryThyrotropin receptorDiagnosis Differential03 medical and health sciencesYoung Adult0302 clinical medicineEndocrinologyAntithyroid AgentsInternal medicineMedicineHumansEuthyroidAgedAutoantibodiesMethimazolebiologybusiness.industryBiochemistry (medical)AutoantibodyReceptors ThyrotropinMiddle Agedmedicine.diseasePrognosisGraves DiseaseGraves OphthalmopathyTiterEndocrinology030220 oncology & carcinogenesisbiology.proteinFemaleAntibodybusinessFollow-Up StudiesThe Journal of clinical endocrinology and metabolism
researchProduct

Ciclosporin and thyroid-stimulating immunoglobulins in endocrine orbitopathy.

1989

The study investigated whether ciclosporin (C) affected the thyroid-stimulating immunoglobulins (TSI) in serum of patients with endocrine orbitopathy (EO). The effect of C was compared with that of prednisone (P). Fifteen patients with EO classes III-V received C (n = 7) or P (n = 8). In addition to the immunosuppressants, five patients with Graves' disease in each group received methimazole (MMI). The stimulation of the cAMP levels in the medium of thyrocyte cultures was determined as a parameter of TSI. The TSI levels were markedly lowered in both groups during and after therapy. C group: before therapy 6.2 pmol/ml +/- 1.63 (100%, mean +/- SEM), during treatment 4.6 pmol/ml +/- 2.28 (74%)…

AdultMalemedicine.medical_specialtymedicine.drug_classGraves' diseasemedicine.medical_treatmentThyroid GlandCyclosporinsPrednisoneInternal medicinemedicineCyclic AMPExophthalmosHumansAgedChemotherapyTriiodothyronineMethimazolebusiness.industryThyroidGeneral MedicineMiddle Agedmedicine.diseaseCiclosporinGraves DiseaseTiterEndocrinologymedicine.anatomical_structureImmunoglobulin GCorticosteroidPrednisoneTriiodothyronineFemalebusinessmedicine.drugImmunoglobulins Thyroid-StimulatingResearch in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie
researchProduct

Impaired Cardiopulmonary Exercise Capacity in Patients With Hyperthyroidism

1996

Hyperthyroidism (H) has been implicated as a primary cause of decreased exercise tolerance. To our knowledge, analysis of respiratory gas exchange, an efficient noninvasive method in evaluating cardiopulmonary capacity, has not been performed in patients with H.Using cardiopulmonary exercise testing, 12 consecutive women with Graves' H were examined and controlled in euthyroidism (E). Eighteen women with E, in whom cardiac catheterization had ruled out heart disease, served as control subjects (C).The ventilatory anaerobic threshold was determined by means of the V-slope method. Ergometry was performed with patients in a semisupine position using a continuous ramp protocol of 20 W/min. Echo…

AdultPulmonary and Respiratory MedicineCardiac outputmedicine.medical_specialtySupine positionAnaerobic ThresholdHeart diseaseRestmedicine.medical_treatmentPhysical exerciseCritical Care and Intensive Care MedicineOxygen ConsumptionAntithyroid AgentsHeart RateInternal medicineHeart rateSupine PositionTidal VolumemedicineHumansProspective StudiesCardiac OutputLungAgedCardiac catheterizationExercise ToleranceMethimazolePulmonary Gas Exchangebusiness.industryHeartStroke VolumeStroke volumeMiddle Agedmedicine.diseaseGraves DiseaseSurgeryEchocardiographyExercise TestLinear ModelsCardiologyFemaleCardiology and Cardiovascular MedicinebusinessAnaerobic exerciseChest
researchProduct

The dynamics of 57Fe nuclei in Fe(II)-DNA and [Fe(II)(1-methyl-2-mercaptoimidazole)2]-DNA condensates.

2002

Abstract Alcoholic solutions of FeCl 2 and Fe II (Hmmi) 2 Cl 2 (Hmmi=1-methyl-2-mercaptoimidazole) induce calf thymus DNA condensation from aqueous solutions buffered at pH 7.4. A 1:1 Fe II –(DNA monomer) stoichiometry is assumed. The 57 Fe Mossbauer hyperfine parameters suggest an octahedral coordination environment, severely distorted, in both Fe II –(DNA monomer) and [Fe II (Hmmi) 2 ]–(DNA monomer) condensates. The dynamic properties of iron nuclei in freeze-dried samples were investigated by means of variable temperature 57 Fe Mossbauer spectroscopy. Mean square displacements, 〈 x 2 〉( T ), were calculated, such as the effective vibrating mass and the Mossbauer lattice temperature of th…

Aqueous solutionMethimazoleMolecular StructureDNAAtmospheric temperature rangeDNA condensationBiochemistryVibrationInorganic ChemistryMetalCrystallographychemistry.chemical_compoundSpectroscopy MossbauerMonomerchemistryOctahedronvisual_artMössbauer spectroscopyvisual_art.visual_art_mediumAnimalsFerrous CompoundsStoichiometryJournal of inorganic biochemistry
researchProduct

Buccal Delivery of Methimazole as an Alternative Means for Improvement of Drug Bioavailability: Permeation Studies and Matrix System Design

2012

The aim of this study was to investigate the potential for systemic administration of Methimazole (MMI) through the buccal mucosa as an alternative route for drug delivery. Considering that the most important restriction in buccal drug delivery could be the low permeability of the mucosa, the ability of MMI to cross the mucosal barrier was assessed. Permeation of MMI through porcine buccal mucosa was investigated ex vivo using Franz type diffusion cells, buffer solution simulating saliva or natural human saliva as donor phase. The collected data suggested that buccal mucosa does not hinder MMI diffusion and the drug crosses the membrane (J(s) = 0.068 mg cm(-2) h(-1) and K(p) = 0.065 cm h(-1…

MaleDrugSwinemedia_common.quotation_subjectAcrylic ResinsBiological AvailabilityPharmacologyPermeabilityDosage formDiffusionExcipientsDrug Delivery SystemsAntithyroid Agentsstomatognathic systemDrug DiscoveryAnimalsHumansSalivamedia_commonPharmacologyMethimazoleChromatographyChemistryMouth MucosaAdministration BuccalBuccal administrationPermeationBioavailabilitySolubilityDrug deliverySystemic administrationEx vivoTabletsCurrent Pharmaceutical Design
researchProduct

Management of Graves‘Thyroidal And Extrathyroidal Disease – An Update

2020

Abstract Context Invited update on the management of systemic autoimmune Graves disease (GD) and associated Graves orbitopathy (GO). Evidence acquisition Guidelines, pertinent original articles, systemic reviews, and meta-analyses. Evidence synthesis Thyrotropin receptor antibodies (TSH-R-Abs), foremost the stimulatory TSH-R-Abs, are a specific biomarker for GD. Their measurement assists in the differential diagnosis of hyperthyroidism and offers accurate and rapid diagnosis of GD. Thyroid ultrasound is a sensitive imaging tool for GD. Worldwide, thionamides are the favored treatment (12-18 months) of newly diagnosed GD, with methimazole (MMI) as the preferred drug. Patients with persistent…

MalePediatricsendocrine system diseasesdiagnosisEndocrinology Diabetes and Metabolismmedicine.medical_treatmentGraves' diseaseClinical Biochemistryradioactive iodineThyroid GlandBiochemistryHyperthyroidismIodine Radioisotopes0302 clinical medicineEndocrinologyPregnancyUltrasonographytreatmentDisease ManagementReceptors ThyrotropinMini-ReviewGraves Disease030220 oncology & carcinogenesisthyroidectomyBiomarker (medicine)antithyroid drugsFemaleAcademicSubjects/MED00250managementmedicine.drugImmunoglobulins Thyroid-Stimulatingmedicine.medical_specialtyendocrine system030209 endocrinology & metabolismContext (language use)TSH receptor antibodiesDiagnosis Differential03 medical and health sciencesAntithyroid AgentsInternal medicinemedicineHumansRisk factorPregnancyMethimazolebusiness.industryBiochemistry (medical)Thyroidectomymedicine.diseaseGraves OphthalmopathyPregnancy ComplicationsEndocrinologyPropylthiouracilDifferential diagnosisbusinessGraves’ diseaseBiomarkersThe Journal of Clinical Endocrinology and Metabolism
researchProduct

Transbuccal delivery of methimazole: ex vivo permeation studies, histomorphological features and matrix system development

2008

MethimazoleBuccal mucosa
researchProduct